These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 13627890)

  • 1. Variation in resistance patterns in different neoplasms.
    POTTER M
    Ann N Y Acad Sci; 1958 Dec; 76(3):630-42. PubMed ID: 13627890
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of uric acid biosynthesis in birds by o-diazoacetyl-L-serine (azaserine) and 6-diazo-5-oxo-L-norleucine (DON).
    KRAKOFF IH; KARNOFSKY DA
    Am J Physiol; 1958 Oct; 195(1):244-50. PubMed ID: 13583156
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparative study of 6-diazo-5-oxo-L-norleucine and O-diazoacety-L-serine on sarcoma 180.
    CLARKE DA; REILLY HC; STOCK CC
    Antibiot Chemother (Northfield); 1957 Dec; 7(12):653-71. PubMed ID: 24544598
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of azaserine and 6-diazo-5-oxo-L-norleucine on the biosynthesis of inosinic acid de novo.
    BUCHANAN JM
    Tex Rep Biol Med; 1957; 15(1):148-53. PubMed ID: 13409287
    [No Abstract]   [Full Text] [Related]  

  • 5. Folic acid antagonists in cancer chemotherapy.
    DELMONTE L; JUKES TH
    Pharmacol Rev; 1962 Mar; 14():91-135. PubMed ID: 13885226
    [No Abstract]   [Full Text] [Related]  

  • 6. Cytochemical effects of azaserine and DON on ribonucleic acid of Ehrlich ascites tumor cells.
    LINDNER A; LARSEN A
    AMA Arch Pathol; 1958 Apr; 65(4):415-9. PubMed ID: 13520053
    [No Abstract]   [Full Text] [Related]  

  • 7. Pyrimidine derivatives. 8. 5-Arylazopyrimidines and their inhibitory effects against transplantable mouse tumors.
    Israel M; Schlein HN; Maddock CL; Farber S; Modest EJ
    J Pharm Sci; 1966 Jun; 55(6):568-72. PubMed ID: 5924119
    [No Abstract]   [Full Text] [Related]  

  • 8. Mechanisms of amethopterin resistance in leukemia. I. Effects of weak folic acid antagonists on mouse leukemias.
    BURCHENAL JH; JOHNSTON SF; WARING GB
    Proc Soc Exp Biol Med; 1951 Oct; 78(1):348-51. PubMed ID: 14892015
    [No Abstract]   [Full Text] [Related]  

  • 9. A mitomycin C-resistant Jensen rat sarcoma: chemotherapy studies.
    Sugiura K; Merker PC
    Cancer Res; 1963 Sep; 23(8 Pt 2):1475-82. PubMed ID: 5878213
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on the nature of resistance of Streptococcus faecalis to folic acid antagonists.
    ANTON AH; NICHOL CA
    Biochem Pharmacol; 1959 Dec; 3():1-9. PubMed ID: 13793858
    [No Abstract]   [Full Text] [Related]  

  • 11. A method for the quantitative comparison of anticancer agents with special reference to a series of folic acid antagonists.
    SLOBODA AE
    J Pharmacol Exp Ther; 1960 Apr; 128():419-27. PubMed ID: 13831692
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of folinic acid on amethopterin-induced inhibition of the Ehrlich ascites carcinoma.
    SARTORELLI AC; UPCHURCH HF; BOOTH BA
    Cancer Res; 1962 Jan; 22():102-6. PubMed ID: 14497283
    [No Abstract]   [Full Text] [Related]  

  • 13. Enhancing cytotoxic sensitivity of tumor cells to antifolates: another opportunity for gene therapy?
    Sirotnak FM
    J Natl Cancer Inst; 1999 Jul; 91(14):1178-9. PubMed ID: 10413407
    [No Abstract]   [Full Text] [Related]  

  • 14. Biosynthesis of the purines. XV. The effect of aza-L-serine and 6-diazo-5-oxo-L-norleucine on inosinic acid biosynthesis de novo.
    LEVENBERG B; MELNICK I; BUCHANAN JM
    J Biol Chem; 1957 Mar; 225(1):163-76. PubMed ID: 13416227
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of combined irradiation and chemotherapy on cancer growth with special reference to studies with folic acid analogues.
    LOKEN MK; KIM YS; MOSSER DG; MARVIN JF
    Radiology; 1959 Aug; 73():166-74. PubMed ID: 14418029
    [No Abstract]   [Full Text] [Related]  

  • 16. Cytotoxic mechanisms of folate antagonists.
    Borsa J
    Ann N Y Acad Sci; 1971 Nov; 186():359-62. PubMed ID: 5289426
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of orally administered 3', 5'-dichloroamethopterin on formate-C14 incorporation in leukemic mice.
    SCHRECKER AW; MEAD JA; LYNCH MR; VENDITTI JM; GOLDIN A
    Cancer Res; 1960 Nov; 20():1457-61. PubMed ID: 13748581
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition of growth of amethopterinsensitive and amethopterin-resistant pairs of lymphocytic neoplasms by dietary folic-acid deficiency in mice.
    POTTER M; BRIGGS GM
    J Natl Cancer Inst; 1962 Feb; 28():341-51. PubMed ID: 14488297
    [No Abstract]   [Full Text] [Related]  

  • 19. Influence of the route of administration on the relative effectiveness of 3',5'-dichloroamethopterin and amethopterin against advanced leukemia (L1210) in mice.
    VENDITTI JM; SCHRECKER AW; MEAD JA; KLINE I; GOLDIN A
    Cancer Res; 1960 Nov; 20():1451-6. PubMed ID: 13780697
    [No Abstract]   [Full Text] [Related]  

  • 20. A new class of cytostatic folic acid antagonists 1-(3,4-dichlorophenyl)-5-isopropyl-biguanide and its boron compounds.
    Bollag W
    Experientia; 1968 Oct; 24(10):1049-50. PubMed ID: 5304711
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.